Related Experiment Video
Updated: Jul 5, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis
Lissbeth Leon1, Jean-François Jeannin, Ali Bettaieb
1EPHE, Laboratoire d'immunologie et immunothérapie des cancers, Inserm U866, Dijon, F-21000, France. leonlissbeth@yahoo.fr
Abstract:
Post-translational modifications of proteins can regulate the balance between survival and cell death signals. It is increasingly recognized that nitric oxide (NO) and reactive oxygen species (ROS)-induced post-translational modifications could play a role in cell death. This review provides an introduction of current knowledge of NO proteins modifications promoting or inhibiting cell death with special attention in cancer cells.
Insights
Nitric oxide (NO) and reactive oxygen species (ROS) modifications impact cell death pathways. This review explores how NO protein modifications influence cancer cell survival and death.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Post-translational modifications (PTMs) are crucial for regulating protein function.
- Nitric oxide (NO) and reactive oxygen species (ROS) are key signaling molecules involved in cellular processes.
- PTMs induced by NO and ROS are increasingly implicated in cell death regulation.
Purpose of the Study:
- To review the current understanding of nitric oxide (NO)-induced protein modifications.
- To elucidate the dual role of NO modifications in promoting or inhibiting cell death.
- To focus on the significance of these modifications in cancer cells.
Main Methods:
- Literature review of existing research on NO, ROS, PTMs, and cell death.
- Analysis of studies investigating specific NO-protein interactions and their functional outcomes.
- Synthesis of data focusing on cancer cell models.
Main Results:
- NO can induce various PTMs, including S-nitrosylation, tyrosine nitration, and S-glutathionylation.
- These NO-induced PTMs can modulate the activity of proteins involved in apoptosis, autophagy, and necrosis.
- Evidence suggests NO modifications can both promote and inhibit cancer cell death depending on context.
Conclusions:
- NO-mediated PTMs represent a critical regulatory mechanism in cell death pathways.
- Targeting NO-protein interactions offers potential therapeutic strategies for cancer treatment.
- Further research is needed to fully delineate the complex roles of NO modifications in cancer biology.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Paracrine Signaling

